Frontlight ResearchEarly access
Trial site
Shulan(Hangzhou) Hospital
- 7running trials
- 2closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Liver and biliary tract cancer5 trials
- Hepatitis B3 trials
- Fatty liver disease (MASLD/MASH)1 trial
- Phase
- Phase 33 trials
- Phase 22 trials
- Early phase 11 trial
- Phase 11 trial
- Status
- Not yet recruiting4 trials
- Recruiting2 trials
- Active, not recruiting1 trial
- Completed1 trial
- Terminated1 trial
- Lead sponsor
- AnHeart Therapeutics Inc.1 trial
- Beijing InnoCare Pharma Tech Co., Ltd.1 trial
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.1 trial
- Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.1 trial
- First Affiliated Hospital of Zhejiang University1 trial
- and 4 more
Running trials
Not yet recruiting
Recruiting
Recruiting
Microbiome and Host Susceptibility in Severe Pneumonia, a Prospective, Multicenter, Cohort Study
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Hepatitis B3 recruiting
- Liver and biliary tract cancer2 recruiting
- Fatty liver disease (MASLD/MASH)1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 17 Nov 2026